{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:31:39Z","timestamp":1790976699041,"version":"4.1.0"},"reference-count":51,"publisher":"American Diabetes Association","issue":"5","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Islets in type 2 diabetes are characterized by a deficit in \u03b2-cells, increased \u03b2-cell apoptosis, and islet amyloid derived from islet amyloid polypeptide (IAPP). The toxic form of amyloidogenic protein oligomers are distinct and smaller than amyloid fibrils and act by disrupting membranes. Using antibodies that bind to toxic IAPP oligomers (but not IAPP monomers or fibrils) and a vaccination-based approach, we sought to establish whether IAPP toxic oligomers form intra- or extracellularly and whether vaccination to induce anti-toxic oligomer antibodies prevents IAPP-induced apoptosis in human IAPP (h-IAPP) transgenic mice.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014Pancreas was sampled from two h-IAPP transgenic mouse models and examined by immunohistochemistry for toxic oligomers. The same murine models were vaccinated with toxic oligomers of Alzheimer \u03b2 protein (A\u03b2P1\u201340) and anti-oligomer titers, and blood glucose and islet pathology were monitored.<\/jats:p>\n               <jats:p>RESULTS\u2014Toxic oligomers were detected intracellularly in \u223c20\u201340% of h-IAPP transgenic \u03b2-cells. Vaccine induced high titers of anti\u2013h-IAPP toxic oligomers in both transgenic models, but \u03b2-cell apoptosis was, if anything, further increased in vaccinated mice, so that neither loss of \u03b2-cell mass nor diabetes onset was delayed.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014IAPP toxic oligomers form in h-IAPP transgenic mouse models, and anti-toxic oligomer antibodies do not prevent h-IAPP\u2013induced \u03b2-cell apoptosis. These data suggest that prevention of h-IAPP oligomer formation may be more useful than a vaccination-based approach in the prevention of type 2 diabetes.<\/jats:p>","DOI":"10.2337\/db06-1579","type":"journal-article","created":{"date-parts":[[2007,4,30]],"date-time":"2007-04-30T16:48:34Z","timestamp":1177951714000},"page":"1324-1332","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":168,"title":["Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP\u2013Induced \u03b2-Cell Apoptosis in h-IAPP Transgenic Mice"],"prefix":"10.2337","volume":"56","author":[{"given":"Chia-Yu","family":"Lin","sequence":"first","affiliation":[{"name":"Larry Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Gurlo","sequence":"additional","affiliation":[{"name":"Larry Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakez","family":"Kayed","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[{"name":"Larry Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Haataja","sequence":"additional","affiliation":[{"name":"Larry Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Glabe","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Butler","sequence":"additional","affiliation":[{"name":"Larry Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031210495594200_R1","doi-asserted-by":"crossref","unstructured":"U.K. prospective diabetes study 16: overview of 6 years' therapy of type II diabetes: a progressive disease: U.K. Prospective Diabetes Study Group. Diabetes\u200844:1249\u20131258,1995","DOI":"10.2337\/diabetes.44.11.1249"},{"key":"2022031210495594200_R2","doi-asserted-by":"crossref","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: \u03b2-Cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes. Diabetes\u200852:102\u2013110,2003","DOI":"10.2337\/diabetes.52.1.102"},{"key":"2022031210495594200_R3","doi-asserted-by":"crossref","unstructured":"Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU: Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res\u20084:110\u2013125,1985","DOI":"10.1159\/000156969"},{"key":"2022031210495594200_R4","doi-asserted-by":"crossref","unstructured":"Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA: Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes\u200839:752\u2013756,1990","DOI":"10.2337\/diabetes.39.6.752"},{"key":"2022031210495594200_R5","doi-asserted-by":"crossref","unstructured":"Degano P, Silvestre RA, Salas M, Peiro E, Marco J: Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner: study in the perfused rat pancreas. Regul Pept\u200843:91\u201396,1993","DOI":"10.1016\/0167-0115(93)90411-Z"},{"key":"2022031210495594200_R6","doi-asserted-by":"crossref","unstructured":"Silvestre RA, Peiro E, Degano P, Miralles P, Marco J: Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul Pept\u200831:23\u201331,1990","DOI":"10.1016\/0167-0115(90)90192-Y"},{"key":"2022031210495594200_R7","doi-asserted-by":"crossref","unstructured":"Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patane G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P: Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that \u03b2-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes\u200851:1437\u20131442,2002","DOI":"10.2337\/diabetes.51.5.1437"},{"key":"2022031210495594200_R8","doi-asserted-by":"crossref","unstructured":"Eizirik DL, Korbutt GS, Hellerstrom C: Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest\u200890:1263\u20131268,1992","DOI":"10.1172\/JCI115989"},{"key":"2022031210495594200_R9","doi-asserted-by":"crossref","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A\u200882:4245\u20134249,1985","DOI":"10.1073\/pnas.82.12.4245"},{"key":"2022031210495594200_R10","doi-asserted-by":"crossref","unstructured":"Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B: Systemic senile amyloidosis: identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest\u200883:836\u2013843,1989","DOI":"10.1172\/JCI113966"},{"key":"2022031210495594200_R11","doi-asserted-by":"crossref","unstructured":"Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl)\u200882:239\u2013259,1991","DOI":"10.1007\/BF00308809"},{"key":"2022031210495594200_R12","doi-asserted-by":"crossref","unstructured":"Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS: Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol\u200810:184\u2013192,1981","DOI":"10.1002\/ana.410100209"},{"key":"2022031210495594200_R13","doi-asserted-by":"crossref","unstructured":"Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P: Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging\u200816:285\u2013298,1995","DOI":"10.1016\/0197-4580(95)00013-5"},{"key":"2022031210495594200_R14","doi-asserted-by":"crossref","unstructured":"Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG: Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem\u2008280:17294\u201317300,2005","DOI":"10.1074\/jbc.M500997200"},{"key":"2022031210495594200_R15","doi-asserted-by":"crossref","unstructured":"Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG: Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem\u2008279:46363\u201346366,2004","DOI":"10.1074\/jbc.C400260200"},{"key":"2022031210495594200_R16","doi-asserted-by":"crossref","unstructured":"Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes\u200848:491\u2013498,1999","DOI":"10.2337\/diabetes.48.3.491"},{"key":"2022031210495594200_R17","doi-asserted-by":"crossref","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science\u2008300:486\u2013489,2003","DOI":"10.1126\/science.1079469"},{"key":"2022031210495594200_R18","doi-asserted-by":"crossref","unstructured":"Betsholtz C, Svensson V, Rorsman F, Engstrom U, Westermark GT, Wilander E, Johnson K, Westermark P: Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp Cell Res\u2008183:484\u2013493,1989","DOI":"10.1016\/0014-4827(89)90407-2"},{"key":"2022031210495594200_R19","doi-asserted-by":"crossref","unstructured":"Betsholtz C, Christmansson L, Engstrom U, Rorsman F, Svensson V, Johnson KH, Westermark P: Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett\u2008251:261\u2013264,1989","DOI":"10.1016\/0014-5793(89)81467-X"},{"key":"2022031210495594200_R20","doi-asserted-by":"crossref","unstructured":"Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A\u200884:8628\u20138632,1987","DOI":"10.1073\/pnas.84.23.8628"},{"key":"2022031210495594200_R21","doi-asserted-by":"crossref","unstructured":"Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A\u200887:5036\u20135040,1990","DOI":"10.1073\/pnas.87.13.5036"},{"key":"2022031210495594200_R22","doi-asserted-by":"crossref","unstructured":"O'Brien TD, Wagner JD, Litwak KN, Carlson CS, Cefalu WT, Jordan K, Johnson KH, Butler PC: Islet amyloid and islet amyloid polypeptide in cynomolgus macaques (Macaca fascicularis): an animal model of human non-insulin-dependent diabetes mellitus. Vet Pathol\u200833:479\u2013485,1996","DOI":"10.1177\/030098589603300501"},{"key":"2022031210495594200_R23","doi-asserted-by":"crossref","unstructured":"Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC: Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A\u200893:7283\u20137288,1996","DOI":"10.1073\/pnas.93.14.7283"},{"key":"2022031210495594200_R24","doi-asserted-by":"crossref","unstructured":"Soeller WC, Janson J, Hart SE, Parker JC, Carty MD, Stevenson RW, Kreutter DK, Butler PC: Islet amyloid-associated diabetes in obese Avy\/a mice expressing human islet amyloid polypeptide. Diabetes\u200847:743\u2013750,1998","DOI":"10.2337\/diabetes.47.5.743"},{"key":"2022031210495594200_R25","doi-asserted-by":"crossref","unstructured":"Butler AE, Janson J, Soeller WC, Butler PC: Increased \u03b2-cell apoptosis prevents adaptive increase in \u03b2-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes\u200852:2304\u20132314,2003","DOI":"10.2337\/diabetes.52.9.2304"},{"key":"2022031210495594200_R26","doi-asserted-by":"crossref","unstructured":"Couce M, Kane LA, O'Brien TD, Charlesworth J, Soeller W, McNeish J, Kreutter D, Roche P, Butler PC: Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and \u03b2-cell dysfunction. Diabetes\u200845:1094\u20131101,1996","DOI":"10.2337\/diab.45.8.1094"},{"key":"2022031210495594200_R27","doi-asserted-by":"crossref","unstructured":"Kayed R, Glabe CG: Conformation-dependent anti-amyloid oligomer antibodies. Methods Enzymol\u2008413:326\u2013344,2006","DOI":"10.1016\/S0076-6879(06)13017-7"},{"key":"2022031210495594200_R28","doi-asserted-by":"crossref","unstructured":"Figueroa DJ, Shi XP, Gardell SJ, Austin CP: Abetapp secretases are co-expressed with Abetapp in the pancreatic islets. J Alzheimers Dis\u20083:393\u2013396,2001","DOI":"10.3233\/JAD-2001-3405"},{"key":"2022031210495594200_R29","doi-asserted-by":"crossref","unstructured":"Sanbe A, Osinska H, Saffitz JE, Glabe CG, Kayed R, Maloyan A, Robbins J: Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci U S A\u2008101:10132\u201310136,2004","DOI":"10.1073\/pnas.0401900101"},{"key":"2022031210495594200_R30","doi-asserted-by":"crossref","unstructured":"Caughey B, Lansbury PT: Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci\u200826:267\u2013298,2003","DOI":"10.1146\/annurev.neuro.26.010302.081142"},{"key":"2022031210495594200_R31","doi-asserted-by":"crossref","unstructured":"Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK: Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci\u200824:3592\u20133599,2004","DOI":"10.1523\/JNEUROSCI.5167-03.2004"},{"key":"2022031210495594200_R32","doi-asserted-by":"crossref","unstructured":"Kienlen-Campard P, Miolet S, Tasiaux B, Octave JN: Intracellular amyloid-beta 1\u201342, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J Biol Chem\u2008277:15666\u201315670,2002","DOI":"10.1074\/jbc.M200887200"},{"key":"2022031210495594200_R33","doi-asserted-by":"crossref","unstructured":"Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC: Diabetes due to a progressive defect in \u03b2-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat): a new model for type 2 diabetes. Diabetes\u200853:1509\u20131516,2004","DOI":"10.2337\/diabetes.53.6.1509"},{"key":"2022031210495594200_R34","doi-asserted-by":"crossref","unstructured":"Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E, Mori M: Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest\u2008109:525\u2013532,2002","DOI":"10.1172\/JCI0214550"},{"key":"2022031210495594200_R35","doi-asserted-by":"crossref","unstructured":"Pipeleers DG: Heterogeneity in pancreatic \u03b2-cell population. Diabetes\u200841:777\u2013781,1992","DOI":"10.2337\/diabetes.41.7.777"},{"key":"2022031210495594200_R36","doi-asserted-by":"crossref","unstructured":"Hock C, Konietzko U, Papassotiropoulos A, Wollmer A, Streffer J, von Rotz RC, Davey G, Moritz E, Nitsch RM: Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. Nat Med\u20088:1270\u20131275,2002","DOI":"10.1038\/nm783"},{"key":"2022031210495594200_R37","doi-asserted-by":"crossref","unstructured":"Jensen MT, Mottin MD, Cracchiolo JR, Leighty RE, Arendash GW: Lifelong immunization with human beta-amyloid (1\u201342) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Neuroscience\u2008130:667\u2013684,2005","DOI":"10.1016\/j.neuroscience.2004.09.055"},{"key":"2022031210495594200_R38","doi-asserted-by":"crossref","unstructured":"Maier M, Seabrook TJ, Lazo ND, Jiang L, Das P, Janus C, Lemere CA: Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response. J Neurosci\u200826:4717\u20134728,2006","DOI":"10.1523\/JNEUROSCI.0381-06.2006"},{"key":"2022031210495594200_R39","doi-asserted-by":"crossref","unstructured":"Lemere CA, Maier M, Jiang L, Peng Y, Seabrook TJ: Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans. Rejuvenation Res\u20089:77\u201384,2006","DOI":"10.1089\/rej.2006.9.77"},{"key":"2022031210495594200_R40","doi-asserted-by":"crossref","unstructured":"Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, Justice A, McConlogue L, Games D, Freedman SB, Morris RG: A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature\u2008408:975\u2013979,2000","DOI":"10.1038\/35050103"},{"key":"2022031210495594200_R41","doi-asserted-by":"crossref","unstructured":"Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, Mathews PM, Jucker M: Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science\u2008298:1379,2002","DOI":"10.1126\/science.1078259"},{"key":"2022031210495594200_R42","doi-asserted-by":"crossref","unstructured":"Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T: Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med\u20086:916\u2013919,2000","DOI":"10.1038\/78682"},{"key":"2022031210495594200_R43","doi-asserted-by":"crossref","unstructured":"Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D: A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature\u2008408:979\u2013982,2000","DOI":"10.1038\/35050110"},{"key":"2022031210495594200_R44","doi-asserted-by":"crossref","unstructured":"Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P: Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature\u2008400:173\u2013177,1999","DOI":"10.1038\/22124"},{"key":"2022031210495594200_R45","doi-asserted-by":"crossref","unstructured":"Kotilinek LA, Bacskai B, Westerman M, Kawarabayashi T, Younkin L, Hyman BT, Younkin S, Ashe KH: Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci\u200822:6331\u20136335,2002","DOI":"10.1523\/JNEUROSCI.22-15-06331.2002"},{"key":"2022031210495594200_R46","doi-asserted-by":"crossref","unstructured":"Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW: A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature\u2008408:982\u2013985,2000","DOI":"10.1038\/35050116"},{"key":"2022031210495594200_R47","doi-asserted-by":"crossref","unstructured":"Selkoe DJ: Alzheimer's disease: genes, proteins, and therapy. Physiol Rev\u200881:741\u2013766,2001","DOI":"10.1152\/physrev.2001.81.2.741"},{"key":"2022031210495594200_R48","doi-asserted-by":"crossref","unstructured":"Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC, Jouanny P, Dubois B, Eisner L, Flitman S, Michel BF, Boada M, Frank A, Hock C: Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology\u200861:46\u201354,2003","DOI":"10.1212\/01.WNL.0000073623.84147.A8"},{"key":"2022031210495594200_R49","doi-asserted-by":"crossref","unstructured":"Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO: Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med\u20089:448\u2013452,2003","DOI":"10.1038\/nm840"},{"key":"2022031210495594200_R50","doi-asserted-by":"crossref","unstructured":"Glabe CG, Kayed R: Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology\u200866:S74\u2013S78,2006","DOI":"10.1212\/01.wnl.0000192103.24796.42"},{"key":"2022031210495594200_R51","doi-asserted-by":"crossref","unstructured":"Gelinas DS, DaSilva K, Fenili D, St George-Hyslop P, McLaurin J: Immunotherapy for Alzheimer's disease. Proc Natl Acad Sci U S A\u2008101:14657\u201314662,2004","DOI":"10.1073\/pnas.0404866101"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/56\/5\/1324\/388756\/zdb00507001324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/56\/5\/1324\/388756\/zdb00507001324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:10:07Z","timestamp":1667405407000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/56\/5\/1324\/15211\/Toxic-Human-Islet-Amyloid-Polypeptide-h-IAPP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db06-1579","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}